Rohan Palekar

Insider Reports History

Entity
Individual
Location
201 Spear Street, Third Floor, San Francisco, California
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rohan Palekar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Chief Executive Officer, Director Common Stock 456K $3.67M $8.04 Aug 17, 2024 Direct
89bio, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 120K Apr 1, 2024 Direct
Neurogene Inc. Director Stock Option (Right to Buy) 7.7K Jun 14, 2024 Direct

Insider Reports Filed by Rohan Palekar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETNB 89bio, Inc. Aug 17, 2024 1 -$37K 4 Aug 19, 2024 Chief Executive Officer, Director
NGNE Neurogene Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
ETNB 89bio, Inc. Apr 1, 2024 3 -$527K 4 Apr 3, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 26, 2024 1 -$48.2K 4 Feb 28, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 17, 2024 1 -$44.8K 4 Feb 23, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 9, 2024 1 -$107K 4 Feb 13, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 1, 2024 3 -$49.7K 4 Feb 5, 2024 Chief Executive Officer, Director
NGNE Neurogene Inc. Jan 16, 2024 1 $0 4 Jan 18, 2024 Director
ETNB 89bio, Inc. Jan 5, 2024 2 -$317K 4 Jan 8, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Dec 29, 2023 3 -$464K 4 Jan 3, 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. Aug 17, 2023 1 -$69.6K 4 Aug 21, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Jun 30, 2023 2 -$313K 4 Jul 5, 2023 Chief Executive Officer, Director
NLTX Neoleukin Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
ETNB 89bio, Inc. Jun 5, 2023 3 -$271K 4 Jun 7, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Mar 31, 2023 2 -$235K 4 Apr 4, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Mar 23, 2023 1 -$240K 4 Mar 27, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 17, 2023 1 -$87.7K 4 Feb 22, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 9, 2023 2 $0 4 Feb 13, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 5, 2023 1 -$54K 4 Feb 7, 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. Sep 28, 2022 2 -$66.4K 4 Sep 30, 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. Sep 8, 2022 2 $193K 4 Sep 9, 2022 Chief Executive Officer, Director
NLTX Neoleukin Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
NLTX Neoleukin Therapeutics, Inc. Mar 2, 2022 1 $0 4 Mar 4, 2022 Director
NLTX Neoleukin Therapeutics, Inc. Mar 2, 2022 0 $0 3 Mar 4, 2022 Director
ETNB 89bio, Inc. Feb 17, 2022 2 $0 4 Feb 22, 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. Feb 5, 2022 1 -$21.4K 4 Apr 13, 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. Jan 27, 2022 2 $52.9K 4 Jan 31, 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. Jul 7, 2021 2 $118K 4 Jul 8, 2021 Chief Executive Officer, Director